Larcaviximab |
| カタログ番号GC72421 |
Larcaviximab（c 4 G 7-N）はIgG 1κ抗エボラウイルス糖タンパク質キメラモノクローナル抗体である。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1792982-56-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Larcaviximab (c4G7-N) is an IgG1 kappa anti-Ebola virus glycoprotein chimeric monoclonal antibody.
References:
[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 30, No. 4, 2016.
Review for Larcaviximab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Larcaviximab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *